{"text": "EBV <extra_id_0> Latent Membrane Protein 1 <extra_id_2> Protein <extra_id_1> Activates <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> in B Cell Lymphomas", "event": "<extra_id_0> <extra_id_0> Positive_regulation Activates <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Cause Latent Membrane Protein 1 <extra_id_1> <extra_id_0> Positive_regulation Activates <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Cause Latent Membrane Protein 1 <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> Latent membrane protein 1 <extra_id_2> Protein <extra_id_1> ( <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> ) is the major oncoprotein of Epstein-Barr virus ( EBV ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "In transgenic mice , <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> promotes increased lymphoma development by 12 mo of age .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This study reveals that lymphoma develops in B-1a lymphocytes , a population that is associated with transformation in older mice .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The lymphoma cells have deregulated cell cycle markers , and inhibitors of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> block the enhanced viability of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells in vitro .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibitors <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Negative_regulation inhibitors <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "Lymphoma cells are independent of <extra_id_0> IL4 <extra_id_2> Protein <extra_id_1> / <extra_id_0> Stat6 <extra_id_2> Protein <extra_id_1> signaling for survival and proliferation , but have constitutively activated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> signaling .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "These same targets are also deregulated in wild-type B-1a lymphomas that arise spontaneously through age predisposition .", "event": "<extra_id_0> <extra_id_0> Regulation deregulated <extra_id_1> <extra_id_1>"}
{"text": "These results suggest that <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> pathways may serve as effective targets in the treatment of EBV - associated B cell lymphomas .", "event": "<extra_id_0> <extra_id_1>"}
